ARCHIVES

FDA Approves Taxotere For Node+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

More Breast Cancer Patients Opt To Remove Both Breasts

November 26, 2010

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

December 11, 1992

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998